| Epidemiology in the Courtroom: Dissonant Goals, Divergent Processes | p. 1 |
| Epidemiology and Law: Dissonant Goals | p. 1 |
| Epidemiology and Law: Divergent Processes | p. 3 |
| Causation in Epidemiology | p. 3 |
| Causation in Law | p. 23 |
| Epidemiological Causation Meets Legal Causation | p. 36 |
| Reconciling Law and Epidemiology | p. 36 |
| Epidemiology, Ethics, and Expert Witnesses | p. 40 |
| Discussion Questions | p. 41 |
| Case Study One: The Silicone Breast Implant Litigation | p. 47 |
| The History of Silicone Breast Implants | p. 47 |
| Epidemiological Findings and Legal Verdicts | p. 50 |
| The Events | p. 50 |
| The Explanations: A Post-Mortem | p. 52 |
| Discussion Questions | p. 59 |
| Case Study Two: The E. Coli Investigation | p. 63 |
| The Epidemiology of E. Coli | p. 63 |
| The Facts | p. 64 |
| The Epidemiological Investigation | p. 65 |
| The Initial Investigation | p. 65 |
| The Case-Control Study | p. 65 |
| The Student Cohort Study | p. 67 |
| The Staff Cohort Study | p. 67 |
| Findings | p. 67 |
| Discovery | p. 70 |
| Plaintiffs' Case | p. 70 |
| Defendant's Case | p. 71 |
| The Trial | p. 76 |
| Plaintiffs' Case | p. 76 |
| Defendant's Case | p. 77 |
| Discussion Questions | p. 79 |
| Epidemiology, Legislation, and Rulemaking | p. 81 |
| Legislatures | p. 81 |
| Legislative Authority | p. 81 |
| Formulating Legislation | p. 82 |
| Influencing Legislation | p. 84 |
| Administrative Agencies | p. 86 |
| Agency Authority | p. 86 |
| Oversight of Agency Activities and Administrative Action | p. 87 |
| Agency Development of Rules | p. 88 |
| Challenging Agency Rules | p. 93 |
| Agency Action in the Face of Uncertainty | p. 93 |
| Influencing Agency Rulemaking | p. 94 |
| Discussion Questions | p. 95 |
| Case Study Three: The FDA and Silicone Breast Implants | p. 97 |
| The FDA and the Regulation of Medical Devices | p. 97 |
| The FDA and Silicone Breast Implants | p. 98 |
| Assessing the FDA's Actions | p. 102 |
| Discussion Questions | p. 102 |
| Case Study Four: The Regulation of Tobacco | p. 105 |
| The FDA and the Regulation of Drugs | p. 105 |
| Tobacco and Its Effects | p. 107 |
| FDA Action and Tobacco | p. 108 |
| Discussion Questions | p. 111 |
| Law, Epidemiology, and Community Organization and Advocacy | p. 115 |
| Defining Advocacy | p. 115 |
| Stages of Development in Community Organization and Advocacy | p. 115 |
| Assessing the Needs of the Community | p. 116 |
| Using Epidemiology for Research | p. 118 |
| Developing Strategies in Community Organization and Advocacy | p. 120 |
| Epidemiology, Advocacy, and Ethics | p. 125 |
| Discussion Questions | p. 126 |
| Case Study Five: Alcohol and Drunk Driving | p. 129 |
| Alcohol and Drunk Driving | p. 129 |
| The Physiological Effects of Alcohol | p. 129 |
| The Characterization of Alcohol Use | p. 129 |
| The Epidemiology of Driving-Related Injuries and Deaths | p. 131 |
| Mothers Against Drunk Drivers | p. 131 |
| The Claim to Moral Authority | p. 132 |
| Goals and Strategies | p. 134 |
| Organizational Characteristics | p. 136 |
| Discussion Questions | p. 136 |
| Case Study Six: Needle Exchange Programs | p. 139 |
| Defining Needle Exchange | p. 139 |
| Needle Exchange and Harm Reduction | p. 139 |
| Needle Exchange Programs: History and Examples | p. 140 |
| The Basis for Needle Exchange | p. 143 |
| Injection Drug Use: Behavior and Biology | p. 143 |
| The Impact of Substance Use and Abuse | p. 144 |
| HIV, AIDS, and Injection Drug Use | p. 145 |
| Hepatitis and Injection Drug Use | p. 146 |
| Public Policy and Needle Exchange | p. 147 |
| Community Activism and the Establishment of Needle Exchange Programs | p. 149 |
| Discussion Questions | p. 149 |
| Epidemiology, Law, and Social Context | p. 153 |
| Deviance in Social Context | p. 153 |
| The Normative View of Deviance | p. 154 |
| The Social Audience Approach | p. 156 |
| Responses to Deviance | p. 158 |
| Deviance at the Juncture of Epidemiology and Law | p. 161 |
| Discussion Questions | p. 163 |
| Case Study Seven: Sex, Gender, and Sexuality | p. 167 |
| Defining Sex | p. 167 |
| Gender Identity and Gender Role | p. 168 |
| Sexual Orientation | p. 169 |
| Transsexuality and Transgenderism | p. 171 |
| Transsexuality | p. 171 |
| Transgenderism | p. 172 |
| Homosexuality, Science, and Changing Social Context | p. 173 |
| Homosexuality in Science and Medicine: Changing Views | p. 173 |
| Homosexuality, Science, and Civil Rights | p. 174 |
| Discussion Questions | p. 178 |
| Case Study Eight: The Medical Use of Marijuana | p. 183 |
| Marijuana, Its Uses, and Its Regulation | p. 183 |
| The Beginnings | p. 183 |
| The Initiation of Drug Regulations | p. 184 |
| Changing Times: States Permit the Medicinal Use of Marijuana | p. 187 |
| The Science of Marijuana as Medicine | p. 187 |
| HIV/AIDS and Marijuana | p. 187 |
| Use of Marijuana for Other Disorders | p. 189 |
| Testing the Effects of Marijuana | p. 190 |
| The Institute of Medicine | p. 190 |
| FDA Procedures | p. 191 |
| The Politics of Marijuana as Medicine | p. 194 |
| Discussion Questions | p. 195 |
| Index | p. 199 |
| Table of Contents provided by Syndetics. All Rights Reserved. |